HAVLF Stock Price, Chart, Stats & News

HAVN Life Sciences Inc.
Save
HAVN Life Sciences Inc. (HAVLF) does not currently pay a dividend.
2,565
Market cap
–
Current P/E
–
Forward P/E
HAVLF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
HAVN Life Sciences Inc. is a biotechnology firm that specializes in the research and innovation of psychotropic compounds derived from botanical and fungal organisms. The company is also dedicated to establishing standardized, quality-controlled methodologies for extracting these psychoactive molecules, with a specific focus on Psilocybe mushroom species and their key constituents such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health products utilizing unregulated ingredients.
Similar securities
Based on sector and market capitalization
Report issue





